InvestorsHub Logo
Followers 58
Posts 10167
Boards Moderated 1
Alias Born 09/21/2016

Re: nidan7500 post# 149549

Monday, 05/07/2018 11:22:30 AM

Monday, May 07, 2018 11:22:30 AM

Post# of 462978
CONCLUSION:

Sig-1R agonists have been used in the treatment of different neurodegenerative diseases, e.g. Alzheimer's and Parkinson's diseases (AD and PD) and amyotrophic lateral sclerosis. Utilization of Sig-1R agents early in AD and similar other diseases has remained an overlooked therapeutic opportunity.




https://www.ncbi.nlm.nih.gov/pubmed/28554311


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News